Pemphigus: Clinical Trials

6 trials for Pemphigus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 22Completed 2

Follow Pemphigus: new trials by email Literature Review of Pemphigus trials Research Report on Pemphigus

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)
efgartigimod PH20 SC, Placebo, prednisone - Pemphigus Vulgaris, Pemphigus Foliaceus
Phase 3Completedargenx2222020-12-012024-10-01
A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)
Mycophenolate Mofetil Placebo, Mycophenolate Mofetil, Rituximab - Pemphigus Vulgaris
Phase 3CompletedHoffmann-La Roche1352015-05-262020-11-10
Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
Rituximab - Pemphigus
Phase 3CompletedUniversity Hospital, Rouen222011-06-012012-09-13
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)
Mycophenolate Mofetil 2 g/Day, Mycophenolate Mofetil (MMF) 3 g/Day, Placebo - Pemphigus Vulgaris (PV)
Phase 3CompletedHoffmann-La Roche962004-05-012011-06-22
Effect of Anti CD20 in Pemphigus Desease
Mabthera - Pemphigus
Phase 2 / Phase 3CompletedUniversity Hospital, Rouen222003-06-012013-06-18
European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
dexamethasone (50mg 1dd6, 3 consecutive days/month) - Pemphigus
Phase 2 / Phase 3CompletedUniversity Medical Center Groningen602001-01-012007-08-30

Broader conditions

Autoimmune Diseases (6)  ·  Immune System Diseases (6)  ·  Skin Diseases (6)  ·  Skin Diseases, Vesiculobullous (6)  ·  Skin and Connective Tissue Diseases (6)

Interventions

Rituximab (3)  ·  Mycophenolic Acid (2)  ·  Dexamethasone (1)  ·  Prednisone (1)

Sponsors

Hoffmann-La Roche (2)  ·  University Hospital, Rouen (2)  ·  University Medical Center Groningen (1)  ·  argenx (1)

Countries

France (4)  ·  Germany (3)  ·  Israel (3)  ·  Turkey (Türkiye) (3)  ·  Ukraine (3)  ·  United States (3)  ·  Australia (2)  ·  Canada (2)  ·  Italy (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  China (1)

Top investigators

Marcel F Jonkman, MD, PhD (1)

Results publications

PMID 16702494, PMID 17687130, PMID 20410913, PMID 34097368

NIH funding

2014 (1)